CSW Industrials (CSW) CEO sells 1,500 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
CSW Industrials Chairman, President & CEO Joseph B. Armes sold 1,500 shares of common stock in an open-market transaction at a weighted average price of $297.79 per share under a pre-established Rule 10b5-1 trading plan. Following this sale, he directly holds 61,026 shares of CSW Industrials common stock.
In addition to common shares, Armes holds various performance rights, each representing a contingent right to receive one share of common stock. These awards can vest between 0% and 200% over performance cycles ending between March 31, 2026 and March 31, 2028, based on CSW Industrials’ relative total shareholder return versus the Russell 2000 Index, and may be settled in cash or stock at the company’s discretion. He also holds restricted stock units that vest in two stages tied to the recruitment and first employment anniversary of a successor Chief Executive Officer, and indirectly holds 3,219 shares through an ESOP.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,500 shares ($446,685)
Net Sell
7 txns
Insider
Armes Joseph B
Role
Chairman, President & CEO
Sold
1,500 shs ($447K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $297.79 | $447K |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Performance Rights | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 61,026 shares (Direct);
Performance Rights — 8,004 shares (Direct);
Restricted Stock Units — 19,685 shares (Direct);
Common Stock — 3,219 shares (Indirect, by ESOP)
Footnotes (1)
- The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025. The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $297.20 to $299.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles ending on each of March 31, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
FAQ
What insider transaction did CSW (CSW) report for Joseph B. Armes?
Joseph B. Armes sold 1,500 CSW Industrials shares in an open-market transaction at a weighted average price of $297.79 per share. The sale was executed under a Rule 10b5-1 trading plan and left him with 61,026 directly held shares.
What performance rights does the CSW (CSW) CEO hold, and how do they vest?
Each performance right held by the CEO can convert into one CSW share. Vesting ranges from 0% to 200% over three-year performance cycles ending between March 31, 2026 and March 31, 2028, based on relative total shareholder return versus the Russell 2000 Index.
How do the CSW Industrials (CSW) restricted stock units for the CEO vest?
Each restricted stock unit represents a contingent right to one CSW share. Forty percent vest upon the successful recruitment and hiring of a successor CEO, while the remaining 60% vest on that successor CEO’s first employment anniversary.
What indirect holdings of CSW (CSW) stock does the CEO report?
In addition to directly owned shares, Joseph B. Armes reports 3,219 CSW Industrials shares held indirectly through an ESOP. These indirect holdings are separate from his direct common stock, performance rights, and restricted stock unit awards.